Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Tavenner to step down

Marilyn Tavenner, top administrator for Centers for Medicare & Medicaid Services, has announced plans to step down in February, reports Wall Street Journal. 

Thumbnail

IOM urges sweeping changes to clinical trial data sharing

The Institute of Medicine has released a report calling for widespread sharing of clinical trial data.

Thumbnail

Cleveland Clinic forms coalition to control healthcare costs, improve quality

Cleveland Clinic is partnering with five other Ohio health systems to build a coalition designed to control healthcare costs and improve quality.

Tavenner to step down at end of February

Marilyn Tavenner, top administrator for Centers for Medicare & Medicaid Services, has announced that she is stepping down from her position at the end of February.

ICD-10 coalition grows again

The Healthcare Leadership Council , a coalition of healthcare chief executives from all disciplines within the U.S. healthcare industry, is the latest organization to join the Coalition for ICD-10 and advocate for U.S. adoption of the ICD-10 coding standard in 2015.

Analysis challenges argument in favor of repealing the medical device tax

An analysis from the Congressional Research Service challenges a common talking point among legislators that the medical device tax destroys jobs and encourages manufacturers to operate oversees, according to The New York Times. 

Thumbnail

IOM issues 4 recommendations for clinical data sharing

The Institute of Medicine has released four recommendations urging significant changes in how clinical trial data are shared, reports Modern Healthcare.  

Paying the price for access

Access to medical records still is proving costly for patients, reports Clinical Innovation + Technology.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.